UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

British journal of cancer, 2010-01, Vol.102 (1), p.144-150

2010

Volltextzugriff (PDF)

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial

Oncology, 2012-01, Vol.82 (2), p.67-74

2012

Volltextzugriff (PDF)

The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

Clinical cancer research, 1999-01, Vol.5 (1), p.119-127

1999

Volltextzugriff (PDF)

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma

Clinical cancer research, 1999-11, Vol.5 (11), p.3403-3410

1999

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms

Clinical cancer research, 2000-05, Vol.6 (5), p.1936-1948

2000

Volltextzugriff (PDF)

Comparison of the Efficacy, Toxicity, and Pharmacokinetics of a Uracil/Tegafur (UFT) Plus Oral Leucovorin (LV) Regimen Between Japanese and American Patients With Advanced Colorectal Cancer: Joint United States and Japan Study of UFT/LV

Journal of clinical oncology, 2004-09, Vol.22 (17), p.3466-3474

2004

Volltextzugriff (PDF)

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

British journal of cancer, 2005-07, Vol.93 (2), p.195-199

2005

Volltextzugriff (PDF)

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

Journal of clinical oncology, 1997-03, Vol.15 (3), p.928-937

1997

Volltextzugriff (PDF)

Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials

Annals of oncology, 2016-06, Vol.27 (6), p.1068-1074

2016

Volltextzugriff (PDF)

Interim Acute Toxicity Analysis and Surgical Outcomes of Neoadjuvant Gemcitabine/nab-Paclitaxel and Hypofractionated Image Guided Intensity Modulated Radiation Therapy in Resectable and Borderline Resectable Pancreatic Cancer (ANCHOR) Study

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S204-S205

2016

Volltextzugriff (PDF)

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

Oncogene, 2004-11, Vol.23 (53), p.8571-8580

2004

Volltextzugriff (PDF)

Constitutive and Inducible Interleukin 8 Expression by Hypoxia and Acidosis Renders Human Pancreatic Cancer Cells More Tumorigenic and Metastatic

Clinical cancer research, 1999-11, Vol.5 (11), p.3711-3721

1999

Volltextzugriff (PDF)

Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer

Investigational new drugs, 2015-08, Vol.33 (4), p.977-984

2015

Volltextzugriff (PDF)

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2094-2103

1995

Volltextzugriff (PDF)

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

Oncogene, 2003-01, Vol.22 (3), p.319-329

2003

Volltextzugriff (PDF)

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM)

Annals of oncology, 2018-10, Vol.29, p.viii453-viii453

2018

Volltextzugriff (PDF)

Surrogate markers in antiangiogenesis clinical trials

British journal of cancer, 2003-07, Vol.89 (1), p.8-14

2003

Volltextzugriff (PDF)

Phase I Trial of Gemcitabine Combined with Radiation for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

Clinical cancer research, 2001-08, Vol.7 (8), p.2246-2253

2001

Volltextzugriff (PDF)

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1272-1280

1994

Volltextzugriff (PDF)

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver : a phase I trial

Gene therapy, 2001-11, Vol.8 (21), p.1618-1626

2001

Volltextzugriff (PDF)

Considerations on Swiss methodologies for rock fall hazard mapping based on trajectory modelling

Natural hazards and earth system sciences, 2009-01, Vol.9 (4), p.1095-1109

2009

Volltextzugriff (PDF)

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3843-3850

1998

Volltextzugriff (PDF)

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

Oncogene, 1999-08, Vol.18 (32), p.4554-4563

1999

Volltextzugriff (PDF)

A multispecialty approach to the diagnosis and management of pancreatic cancer

The American journal of gastroenterology, 2000-01, Vol.95 (1), p.17-31

2000

Volltextzugriff (PDF)

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells

Oncogene, 2009-02, Vol.28 (5), p.709-720

2009

Volltextzugriff (PDF)

1 – 25 von 743

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(652)
Mit Volltextzugriff
(662)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(418)
Life Sciences & Biomedicine
(378)
Humans
(363)
Oncology
(254)
Biological And Medical Sciences
(229)
Male
(224)
Female
(217)
Medical Sciences
(213)
Middle Aged
(192)
Aged
(164)
Adult
(160)
Tumors
(128)
Pharmacology. Drug Treatments
(104)
Antineoplastic Agents
(100)
Chemotherapy
(79)
Gastroenterology. Liver. Pancreas. Abdomen
(74)
Pancreatic Neoplasms - Pathology
(74)
Animals
(73)
Pancreatic Cancer
(72)
Pancreatic Neoplasms - Drug Therapy
(68)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial

The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma

Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms

Comparison of the Efficacy, Toxicity, and Pharmacokinetics of a Uracil/Tegafur (UFT) Plus Oral Leucovorin (LV) Regimen Between Japanese and American Patients With Advanced Colorectal Cancer: Joint United States and Japan Study of UFT/LV

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials

Interim Acute Toxicity Analysis and Surgical Outcomes of Neoadjuvant Gemcitabine/nab-Paclitaxel and Hypofractionated Image Guided Intensity Modulated Radiation Therapy in Resectable and Borderline Resectable Pancreatic Cancer (ANCHOR) Study

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells

Constitutive and Inducible Interleukin 8 Expression by Hypoxia and Acidosis Renders Human Pancreatic Cancer Cells More Tumorigenic and Metastatic

Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM)

Surrogate markers in antiangiogenesis clinical trials

Phase I Trial of Gemcitabine Combined with Radiation for the Treatment of Locally Advanced Pancreatic Adenocarcinoma

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver : a phase I trial

Considerations on Swiss methodologies for rock fall hazard mapping based on trajectory modelling

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA

A multispecialty approach to the diagnosis and management of pancreatic cancer

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells

Suchergebnisse filtern